Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunogenetics

J J van Rood1

  • 1Academisch Ziekenhuis Leiden, The Netherlands.

Current Opinion in Hematology
|November 1, 1994
PubMed
Summary
This summary is machine-generated.

Understanding HLA and minor histocompatibility systems is crucial for selecting bone marrow donors. New DNA typing methods reveal past HLA mismatches, highlighting the need to identify safe transplant combinations.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

When selecting a cord blood unit from a firstborn donor verify that the patient shares an Ag with the unit that is foreign to the mother of the donor.

Bone marrow transplantation·2017
Same author

Physiochemical disparity of mismatched HLA class I alloantigens and risk of acute GVHD following HSCT.

Bone marrow transplantation·2015
Same author

HLA A, B, DR and endothelial-specific antigens in kidney-graft rejection.

Immunology today·2014
Same author

Translating in vitro prediction of cytotoxic T cell alloreactivity to hematopoietic stem cell transplantation outcome.

Transplant immunology·2014
Same author

The impact of frequent HLA haplotypes in high linkage disequilibrium on donor search and clinical outcome after unrelated haematopoietic SCT.

Bone marrow transplantation·2012
Same author

Access to allogeneic hematopoietic SCT for patients with MDS or relapsed AML treated according to protocols of the Dutch Childhood Oncology Group.

Bone marrow transplantation·2011
Same journal

Dynamic myeloid suppressor states in cancer and inflammation and their therapeutic potential.

Current opinion in hematology·2026
Same journal

Factor XIa inhibition for the prevention of thrombosis: mechanism, clinical trial signals, and indication-specific positioning.

Current opinion in hematology·2026
Same journal

Nutrition as a regulator of hematopoietic stem cell biology and transplantation.

Current opinion in hematology·2026
Same journal

From biomimicry to clinical actionability: rethinking high-shear thrombosis as a mechanobiological system.

Current opinion in hematology·2026
Same journal

Bidirectional relationship between metabolic and thrombotic disease mechanisms.

Current opinion in hematology·2026
Same journal

The dual role of the brain-derived neurotrophic factor as a regulator of hemostasis and thrombotic risk.

Current opinion in hematology·2026
See all related articles

Area of Science:

  • Immunogenetics
  • Molecular Biology
  • Transplantation Immunology

Background:

  • The Human Leukocyte Antigen (HLA) system is highly complex, influencing bone marrow donor selection.
  • Non-HLA or minor histocompatibility systems also play a critical role in transplant outcomes.
  • Over 50 HLA genes on chromosome 6 have been identified, with numerous alleles for HLA-class I and II.

Purpose of the Study:

  • To explore the immunogenetics of HLA and minor histocompatibility systems.
  • To understand the impact of HLA complexity on unrelated bone marrow donor selection.
  • To identify criteria for successful mismatched bone marrow transplants.

Main Methods:

  • Utilizing advanced technologies like polymerase chain reaction (PCR) for DNA-level HLA typing.

Related Experiment Videos

  • Mapping the genetic complexity of the HLA system.
  • Analyzing clinical outcomes of HLA-mismatched transplants.

    • Main Results:

    • Modern DNA typing reveals many previously considered HLA-matched transplants were actually mismatched.
    • Minor histocompatibility antigens (HA-1 to -5) are recognized by T-cells and can cause graft-versus-host disease.
    • Despite mismatches, many transplants have shown good clinical outcomes.

    Conclusions:

    • Accurate HLA and minor histocompatibility antigen matching is essential for bone marrow transplantation.
    • New genetic insights necessitate re-evaluation of past transplant matching criteria.
    • Further research is needed to predict which mismatched transplants are safe and which should be avoided.